Ultimately, differences in the frequency of mammary tumors between mice treated with DMBA one week or 12 weeks after pituitary transplant may be explained by increased ovarian hormonal stimulation by pituitaries transplanted closer to the time of DMBA treatment limiting our assessment of Cx26 in mice treated with DMBA one week following pituitary isograft. Here, GJB2 is linked to breast cancer.